Published in Am J Gastroenterol on February 01, 2003
Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol (2008) 1.34
Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut (2005) 1.07
Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis. Clin Exp Immunol (2010) 0.90
Primary biliary cirrhosis: family stories. Autoimmune Dis (2011) 0.89
Immunopathogenesis of primary biliary cirrhosis: an old wives' tale. Immun Ageing (2011) 0.84
Epitope-specific anti-nuclear antibodies are expressed in a mouse model of primary biliary cirrhosis and are cytokine-dependent. Clin Exp Immunol (2012) 0.82
Epstein-barr virus as a trigger of autoimmune liver diseases. Adv Virol (2012) 0.81
Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges. Int J Rheumatol (2011) 0.81
Sex differences associated with primary biliary cirrhosis. Clin Dev Immunol (2012) 0.80
Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22. Auto Immun Highlights (2011) 0.79
Hair dyes as a risk for autoimmunity: from systemic lupus erythematosus to primary biliary cirrhosis. Auto Immun Highlights (2012) 0.78
Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies. Auto Immun Highlights (2012) 0.75
Popular and unpopular infectious agents linked to primary biliary cirrhosis. Auto Immun Highlights (2012) 0.75
The X-factor in primary biliary cirrhosis: monosomy X and xenobiotics. Auto Immun Highlights (2012) 0.75
Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol (2003) 2.69
Diagnosis and management of autoimmune hepatitis. Hepatology (2010) 5.27
Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology (2012) 2.81
Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis. Hepatology (2014) 2.29
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology (2002) 1.77
Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol (2006) 1.70
Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology (2007) 1.68
Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? Gastroenterology (2006) 1.64
Serial circulating markers of inflammation in biliary atresia--evolution of the post-operative inflammatory process. Hepatology (2007) 1.61
Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol (2004) 1.54
Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis. Hepatology (2010) 1.51
The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol (2008) 1.50
Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis. Hepatology (2013) 1.47
Immunohistochemical phenotyping of the inflammatory infiltrate in de novo autoimmune hepatitis after liver transplantation in children. Pediatr Transplant (2012) 1.38
Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol (2008) 1.34
Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology (2006) 1.30
Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol (2002) 1.24
Autoimmune hepatitis: a comprehensive review. J Autoimmun (2012) 1.16
The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol (2007) 1.16
The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol (2008) 1.15
Autoimmune hepatitis. Nat Rev Gastroenterol Hepatol (2011) 1.14
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun (2010) 1.13
Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun (2005) 1.13
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology (2010) 1.10
Autoimmune hepatitis. J Pediatr Gastroenterol Nutr (2009) 1.09
The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway. Hepatology (2012) 1.09
Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol (2004) 1.06
Liver transplantation in children. J Hepatol (2006) 1.06
Biliary atresia. Semin Immunopathol (2009) 1.05
Aetiopathogenesis of autoimmune hepatitis. J Autoimmun (2009) 1.04
Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology (2005) 1.03
Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology (2006) 1.03
Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis (2009) 1.02
Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology (2005) 1.02
New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem (2009) 0.99
Autoimmune paediatric liver disease. World J Gastroenterol (2008) 0.99
Inhibition of interleukin-17 promotes differentiation of CD25⁻ cells into stable T regulatory cells in patients with autoimmune hepatitis. Gastroenterology (2012) 0.99
Autoimmune hepatitis in children: what is different from adult AIH? Semin Liver Dis (2009) 0.98
Autoimmune hepatitis after liver transplantation. Clin Gastroenterol Hepatol (2011) 0.98
Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol (2005) 0.96
Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver Int (2007) 0.96
The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Dis Markers (2010) 0.96
Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol (2003) 0.95
Antimitochondrial and other autoantibodies. Clin Liver Dis (2003) 0.94
Bacteria and primary biliary cirrhosis. Clin Rev Allergy Immunol (2009) 0.94
Clinical significance of autoantibodies in autoimmune hepatitis. J Autoimmun (2013) 0.93
Role of monocytes and macrophages in experimental and human acute liver failure. World J Gastroenterol (2010) 0.93
Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy. J Virol (2010) 0.93
Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis. Hepatology (2008) 0.93
Pathogenesis of autoimmune hepatitis. Best Pract Res Clin Gastroenterol (2011) 0.92
Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells. Hepatology (2009) 0.92
Autoimmune liver diseases in children - what is different from adulthood? Best Pract Res Clin Gastroenterol (2011) 0.91
Autoimmunity and environment: am I at risk? Clin Rev Allergy Immunol (2012) 0.91
Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. Hepatology (2007) 0.90
Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter? Clin Infect Dis (2005) 0.89
Actin-free Gc globulin: a rapidly assessed biomarker of organ dysfunction in acute liver failure and cirrhosis. Liver Transpl (2007) 0.88
Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis. Intensive Care Med (2010) 0.88
Combined lamivudine/interferon-alpha treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study. J Pediatr (2006) 0.87
Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease. Autoimmunity (2002) 0.86
Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. Clin Chim Acta (2007) 0.86
Paralysed monocytes in acute on chronic liver disease. J Hepatol (2005) 0.86
Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. Am J Gastroenterol (2004) 0.86
Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis. J Hepatol (2008) 0.86
Autoimmune hepatitis in children. Clin Liver Dis (2002) 0.86
Cytokine levels and profiles in children related to sickle cell disease and asthma status. J Interferon Cytokine Res (2011) 0.85
Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review. J Autoimmun (2013) 0.85
Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure. Hepatology (2014) 0.85
High prevalence of food sensitisation in young children with liver disease: a clue to food allergy pathogenesis? Pediatr Allergy Immunol (2012) 0.84
Human CD4+CD25(high)CD127 (low/neg) regulatory T cells. Methods Mol Biol (2012) 0.84
Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis. J Autoimmune Dis (2004) 0.84
Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol (2002) 0.84
Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis. Clin Chem (2004) 0.83
De novo autoimmune hepatitis after liver transplantation. J Hepatol (2004) 0.83
Disease-specific autoantibodies in patients with acute liver failure: the King's College London Experience. Hepatology (2008) 0.83
Origin of cross-reactive autoimmunity in primary biliary cirrhosis. Liver Int (2006) 0.83
Unique features of primary sclerosing cholangitis in children. Curr Opin Gastroenterol (2010) 0.82
Adaptive immunity in autoimmune hepatitis. Dig Dis (2010) 0.82
Regulatory T cells: Mechanisms of suppression and impairment in autoimmune liver disease. IUBMB Life (2015) 0.81
Viruses and autoantibodies in biliary atresia. Gastroenterology (2010) 0.81
Liver transplantation and autoimmune liver diseases. Liver Transpl (2013) 0.81
Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies. Eur J Gastroenterol Hepatol (2009) 0.81
Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity. J Hepatol (2003) 0.81
A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics. Clin Dev Immunol (2005) 0.81
Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis. Clin Chim Acta (2012) 0.81
Paediatric Autoimmune Liver Disease. Dig Dis (2015) 0.80
T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile. J Autoimmun (2013) 0.80
Unusual suspects in primary biliary cirrhosis. Hepatology (2004) 0.80
Identification of T cell epitopes on soluble liver antigen in Chinese patients with auto-immune hepatitis. Liver Int (2011) 0.79
Effect of ethnicity on the clinical presentation and outcome of autoimmune hepatitis. Expert Rev Gastroenterol Hepatol (2012) 0.79
Treatment of hepatitis B virus in children: why, whom, how? Indian J Gastroenterol (2006) 0.79
Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease. J Crohns Colitis (2010) 0.79
Non-organ-specific autoantibodies in children with chronic hepatitis C virus infection. Clin Infect Dis (2004) 0.79
Steroid-responsive autoimmune sclerosing cholangitis with liver granulocytic epithelial lesions. J Pediatr Gastroenterol Nutr (2013) 0.78
Neonatal liver disease associated with placental transfer of anti-mitochondrial antibodies. Autoimmunity (2002) 0.78
Autoantibody and human leukocyte antigen profiles in children with autoimmune liver disease and their first-degree relatives. J Pediatr Gastroenterol Nutr (2014) 0.78
Serum autoantibodies: a road map for the clinical hepatologist. Autoimmunity (2008) 0.78
Paediatric autoimmune liver disease. Arch Dis Child (2013) 0.77
"Neonatal hemochromatosis": a re-vision. Hepatology (2010) 0.77
Hepatitis B virus: something old, something new. J Pediatr Gastroenterol Nutr (2007) 0.77